Therefore, anthralin should be stable in therapeutical prescriptions, but oxidation in vivo should not be prevented. Anthralin has dual solubility characteristics due to the hydrophilic hydroxyl and carbonyl groups and the lipophilic 10-methylene group [1] . It is, however, relatively unstable in aqueous or alcoholic solutions [7, 11] , but relatively stable in white soft paraffin [8] .
Liposomes, consisting of phospholipids and forming vesicles in aqueous solutions, have been shown to be ideal carriers and penetration enhancers for some topical dermatological drugs, e.g. glucocorticoids and antimycotics [3, 4] . We therefore tested anthralin stability in phospholipid liposomes. Two different phospholipid mixtures were used for the formulation of liposomes (Table 1) . Formulations 1, 2 and 3 contained mainly phosphatidylcholine and phosphatidylethanolamine, which meant that these liposomes did not carry electrical charges and were mainly lipophilic. Formulation 4 contained a large amount of negatively charged phospholipids resulting in electrically charged liposomes at physiological pH with hydrophilic characteristics. There was virtually no difference in particle size and lamellarity between the four formulations.
Formulation 3 had a higher content of electrolytes than the other formulations, in which liposomes were fixed in a gel matrix. Liposomes in formulation 3 were mobile in a dispersion, since electrolytes prevent the forOffprint requests to: G. Mahrle mation of a gel matrix. The main fatty acids in the phospholipids were linoleic acid (75%) and linolenic acid (7%). The ratio of unsaturated to saturated fatty acids was 9 : 1 in all formulations.
Formulation 2 was enriched with 10% primrose oil which contained 71% linoleic acid, 7% oleic acid, 10% 7-1inolenic acid, 9% pahnitic acid, 1% stearic acid, and 2% other fatty acids [2] . The ratio of unsaturated to saturated fatty acids was 9 : 1, the same as in the original liposomal phospholipids. In addition to the fatty acid composition of formulations 1, 3 and 4, with 7% c~-linolenic acid, formulation 2 contained 1% p-linolenic acid.
Fresh 1% anthralin phospholipid was prepared by incorporation of 50 mg purified anthralin in 5 g of the vehicle. Purification was by column chromatography (SiOz, dichloromethane). During the time of investigation the preparation was stored at 5~ under light protection. Samples were taken at different intervals and analysed by thin layer chromatography [15] . C4-1actone, a hydrophilic derivative of anthralin with a lacton ring at position 10, was synthesized as described e.lsewhere [16] . C4-1actone (derivative X) has been shown 1:o inhibit cell growth in vitro more effectively and to be Iess toxic than anthralin [5] . It was therefore compared with anthralin, using a 1% concentration in phospholipids.
We found that anthralin rapidly degraded in formulation 2, less rapidly in formulations 1 and 3, and relatively slowly in formulation 4 ( Table 2 ). This meant that there was virtually no difference between the degradation time in the gel or the dispersion formulations 1 and 3, even though anthralin was less soluble in the dispersion than in the gel. The addition of primrose oil reduced the degradation time. The lowest anthralin degradation rate was obtained with the liposome preparation containing a higher content of negatively charged phospholipids. C4-1actone was more stable than anthralin, at least in formulations 2 and 3.
The results demonstrate that anthralin is oxidized within days in liposomal phospholipids. The oxidation process is retarded by using liposomes consisting mostly 
of negatively charged phospholipids. Compared with other vehicles (Table 3) anthralin in phospholipids was less stable than in white soft paraffin, but more stable than in aqueous or acetone solutions. 
